Understanding the Role of Endoscopic Ultrasonography in Early Gastric Cancer by �씠�긽湲�
Editorial
Gut and Liver, Vol. 10, No. 1, January 2016, pp. 3-5
Understanding the Role of Endoscopic Ultrasonography in Early Gastric 
Cancer
Chan Hyuk Park* and Sang Kil Lee†
*Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, and †Division of 
Gastroenterology, Department of Internal Medicine, Severance Hospital, Institute of Gastroenterology, Yonsei University College of Medicine, 
Seoul, Korea 
Endoscopic submucosal dissection (ESD) has been widely 
used to treat early gastric cancer (EGC) with expanded indica-
tions.1,2 The expanded indications for ESD proposed by Gotoda3 
consist of four categories based on a combination of multiple 
tumor characteristics including tumor differentiation, depth of 
tumor invasion, tumor size, presence of ulcers, and presence of 
lymphovascular invasion. However, predicting whether a tumor 
fulfills the indication criteria by using endoscopy with biopsy 
alone is difficult.1 When a tumor resected through ESD does not 
meet the ESD indication criteria, subsequent surgery should be 
performed because of the possibility of lymph node metastasis. 
However, some patients with EGC undergo unnecessary surgery 
even when the lesion meets the ESD indication criteria.
To solve this problem, endoscopic ultrasonography (EUS) has 
been performed to increase the accuracy of predicting the depth 
of tumor invasion. Meta-analyses have shown the high sensi-
tivity and specificity of EUS in predicting the T stage of gastric 
cancer.4,5 However, the ability of EUS to distinguish mucosal 
cancer from submucosal cancer remains in doubt.6 This doubt is 
concerning because the therapeutic decision between ESD and 
surgery for EGC with a differentiated histology might primar-
ily depend on the presence of the submucosal invasion of the 
tumor. If EUS does not decrease the proportion of additional 
treatments after ESD, or that of unnecessary surgery, then there 
is no need to perform EUS before EGC.
A recent study by Lee et al.,7 published in Gut and Liver, has 
approached this issue directly. In that study, EUS did not in-
crease the likelihood of selecting the appropriate treatment for 
EGC with a differentiated histology. The appropriate treatment 
selection rates were 75.3% and 71.5% for the endoscopy- and 
EUS-based approaches, respectively, and these rates were not 
significantly different. In the case of endoscopically presumed 
mucosal cancer, however, an EUS-based treatment approach 
was inferior to its endoscopy-based counterpart. The authors 
demonstrated the nonrequirement for EUS by using a hypo-
thetical treatment algorithm. Performing EUS routinely before 
treatment may not be necessary in patients with EGC.
However, certain issues remain to be discussed. All patients 
with EGC undergo endoscopic examination regardless of 
whether they undergo EUS examination. No endoscopist should 
ignore the endoscopic findings during selection of the treatment 
plan. Therefore, therapeutic decision-making on the basis of 
EUS alone is unrealistic. Furthermore, a treatment plan based on 
endoscopy with EUS might be more clinically meaningful than 
a treatment plan based on EUS alone. Lee et al.7 have reported 
that seven of 45 patients (8.3%) with endoscopically presumed 
submucosal cancer successfully underwent ESD after an EUS-
based treatment plan. In contrast, only one patient (1.2%) with 
endoscopically presumed submucosal cancer needed surgery 
after ESD after an EUS-based treatment plan. Although this 
finding was not significant, it suggests that EUS may play a 
supporting role in conventional endoscopy. Here, we suggest an 
algorithm for determining the depth of tumor invasion by using 
both endoscopy and EUS in patients with EGC with a differenti-
ated histology (Fig. 1). Using this algorithm, EUS is necessary 
only when EGC is estimated to be beyond the absolute indica-
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tion for ESD upon conventional endoscopy. When the tumor 
appears to be confined to the mucosa upon EUS, ESD is recom-
mended as the initial treatment method even when the lesion 
appears to be beyond the absolute indication for ESD upon con-
ventional endoscopy. This algorithm emphasizes the supporting 
role of EUS in minimizing the number of patients who undergo 
unnecessary surgery. We hope that the supporting role of EUS 
will be proven through future studies.
Another discussion point is the variation in the gastric can-
cer population. In Korea and Japan, early-stage gastric cancer, 
especially mucosal cancer, is more prevalent than advanced 
gastric cancer.1,8-10 Lee et al.7 have shown that the sensitivity 
for predicting mucosal cancer is higher for the diagnosis based 
on endoscopy (endoscopy, 83.2% vs EUS, 66.9%), whereas the 
specificity for predicting mucosal cancer is higher for the diag-
nosis based on EUS (endoscopy, 56.5% vs EUS, 86.8%). Given 
that the overall accuracy of a diagnostic tool with a high sen-
sitivity and low specificity increases as the incidence or preva-
lence increases, an endoscopy-based treatment plan should be 
favored over an EUS-based treatment plan in Korea and Japan. 
However, in Western countries where mucosal cancer is less 
prevalent, EUS might play a larger role in planning the treat-
ment strategy. If mucosal cancer is extremely rare among EGCs, 
then the relatively low specificity of endoscopy might signifi-
cantly increase the performance of unnecessary ESD procedures 
under a treatment plan based on endoscopy alone.
Lee et al.7 have described the clinical role that EUS plays 
in choosing between ESD and surgery for patients with EGC. 
Routine EUS examination for therapeutic decision making may 
no longer be necessary. However, EUS might be an optional 
diagnostic modality because of its discriminatory ability in 
endoscopically presumed submucosal cancer. In addition, the 
relatively higher specificity of EUS compared with endoscopy 
should be considered when discussing the accuracy of EUS for 
predicting mucosal cancer because this accuracy depends on the 
incidence of mucosal cancer.
CONFLICTS OF INTEREST
No potential conflict of interest relevant to this article was 
reported.
REFERENCES
1. Park CH, Shin S, Park JC, et al. Long-term outcome of early gas-
tric cancer after endoscopic submucosal dissection: expanded in-
dication is comparable to absolute indication. Dig Liver Dis 2013; 
45:651-656.
2. Isomoto H, Shikuwa S, Yamaguchi N, et al. Endoscopic submu-
cosal dissection for early gastric cancer: a large-scale feasibility 
study. Gut 2009;58:331-336.
3. Gotoda T. Endoscopic resection of early gastric cancer. Gastric 
Cancer 2007;10:1-11.
4. Puli SR, Batapati Krishna Reddy J, Bechtold ML, Antillon MR, 
Ibdah JA. How good is endoscopic ultrasound for TNM staging of 
gastric cancers? A meta-analysis and systematic review. World J 
Gastroenterol 2008;14:4011-4019.
5. Mocellin S, Marchet A, Nitti D. EUS for the staging of gastric can-
Fig. 1. An algorithm for making de-
signing a treatment plan in for pa-
tients with early gastric cancer (EGC) 
with a differentiated histology.
ESD, endoscopic submucosal dis-
section; EUS, endoscopic ultraso-
nography.
EGC with differentiated histology
Conventional endoscopy
Within absolute indication of ESD
under conventional endoscopy
Beyond absolute indication of ESD
under conventional endoscopy
EUS
Mucosal cancer
under EUS
Submucosal
cancer under EUS
ESD
Surgery
Beyond expanded
indication of ESD
Within expanded
indication of ESD
Park CH and Lee SK: Understanding the Role of Endoscopic Ultrasonography in Early Gastric Cancer  5
cer: a meta-analysis. Gastrointest Endosc 2011;73:1122-1134.
6. Choi J, Kim SG, Im JP, Kim JS, Jung HC, Song IS. Is endoscopic 
ultrasonography indispensable in patients with early gastric cancer 
prior to endoscopic resection? Surg Endosc 2010;24:3177-3185.
7. Lee JY, Choi IJ, Kim CG, et al. Therapeutic decision-making using 
endoscopic ultrasonography in endoscopic treatment of early gas-
tric cancer. Gut Liver 2016;10:42-50.
8. Park CH, Kim B, Chung H, et al. Endoscopic quality indicators for 
esophagogastroduodenoscopy in gastric cancer screening. Dig Dis 
Sci 2015;60:38-46.
9. Gotoda T, Yanagisawa A, Sasako M, et al. Incidence of lymph 
node metastasis from early gastric cancer: estimation with a large 
number of cases at two large centers. Gastric Cancer 2000;3:219-
225.
10. Takatsu Y, Hiki N, Nunobe S, et al. Clinicopathological features of 
gastric cancer in young patients. Gastric Cancer. Epub 2015 Mar 
10. http://dx.doi.org/10.1007/s10120-015-0484-1.
